,PUBCHEM_RESULT_TAG,PUBCHEM_SID,PUBCHEM_CID,PUBCHEM_EXT_DATASOURCE_SMILES,PUBCHEM_ACTIVITY_OUTCOME,PUBCHEM_ACTIVITY_SCORE,PUBCHEM_ACTIVITY_URL,PUBCHEM_ASSAYDATA_COMMENT,Phenotype-Replicate_1,Potency-Replicate_1,Efficacy-Replicate_1,Analysis Comment-Replicate_1,Activity_Score-Replicate_1,Curve_Description-Replicate_1,Fit_LogAC50-Replicate_1,Fit_HillSlope-Replicate_1,Fit_R2-Replicate_1,Fit_InfiniteActivity-Replicate_1,Fit_ZeroActivity-Replicate_1,Fit_CurveClass-Replicate_1,Excluded_Points-Replicate_1,Max_Response-Replicate_1,Activity at 0.0000074871 uM-Replicate_1,Activity at 0.0000171744 uM-Replicate_1,Activity at 0.0000679832 uM-Replicate_1,Activity at 0.0001616562 uM-Replicate_1,Activity at 0.0003744726 uM-Replicate_1,Activity at 0.0007728037 uM-Replicate_1,Activity at 0.00212 uM-Replicate_1,Activity at 0.00651 uM-Replicate_1,Activity at 0.017 uM-Replicate_1,Activity at 0.038 uM-Replicate_1,Activity at 0.085 uM-Replicate_1,Activity at 0.191 uM-Replicate_1,Activity at 0.435 uM-Replicate_1,Activity at 1.330 uM-Replicate_1,Activity at 4.074 uM-Replicate_1,Activity at 10.46 uM-Replicate_1,Activity at 23.64 uM-Replicate_1,Activity at 52.95 uM-Replicate_1,Activity at 115.2 uM-Replicate_1,Activity at 299.6 uM-Replicate_1,Activity at 1087.9 uM-Replicate_1,Activity at 2306.0 uM-Replicate_1,Activity at 5157.0 uM-Replicate_1,Activity at 11530.0 uM-Replicate_1,Activity at 25780.0 uM-Replicate_1,Activity at 57660.0 uM-Replicate_1,Compound QC-Replicate_1,Phenotype-Replicate_2,Potency-Replicate_2,Efficacy-Replicate_2,Analysis Comment-Replicate_2,Activity_Score-Replicate_2,Curve_Description-Replicate_2,Fit_LogAC50-Replicate_2,Fit_HillSlope-Replicate_2,Fit_R2-Replicate_2,Fit_InfiniteActivity-Replicate_2,Fit_ZeroActivity-Replicate_2,Fit_CurveClass-Replicate_2,Excluded_Points-Replicate_2,Max_Response-Replicate_2,Activity at 0.0000074871 uM-Replicate_2,Activity at 0.0000171744 uM-Replicate_2,Activity at 0.0000679832 uM-Replicate_2,Activity at 0.0001616562 uM-Replicate_2,Activity at 0.0003744726 uM-Replicate_2,Activity at 0.0007728037 uM-Replicate_2,Activity at 0.00212 uM-Replicate_2,Activity at 0.00651 uM-Replicate_2,Activity at 0.017 uM-Replicate_2,Activity at 0.038 uM-Replicate_2,Activity at 0.085 uM-Replicate_2,Activity at 0.191 uM-Replicate_2,Activity at 0.435 uM-Replicate_2,Activity at 1.330 uM-Replicate_2,Activity at 4.074 uM-Replicate_2,Activity at 10.46 uM-Replicate_2,Activity at 23.64 uM-Replicate_2,Activity at 52.95 uM-Replicate_2,Activity at 115.2 uM-Replicate_2,Activity at 299.6 uM-Replicate_2,Activity at 1087.9 uM-Replicate_2,Activity at 2306.0 uM-Replicate_2,Activity at 5157.0 uM-Replicate_2,Activity at 11530.0 uM-Replicate_2,Activity at 25780.0 uM-Replicate_2,Activity at 57660.0 uM-Replicate_2,Phenotype-Replicate_3,Potency-Replicate_3,Efficacy-Replicate_3,Analysis Comment-Replicate_3,Activity_Score-Replicate_3,Curve_Description-Replicate_3,Fit_LogAC50-Replicate_3,Fit_HillSlope-Replicate_3,Fit_R2-Replicate_3,Fit_InfiniteActivity-Replicate_3,Fit_ZeroActivity-Replicate_3
0,RESULT_TYPE,,,,,,,,STRING,FLOAT,FLOAT,STRING,INTEGER,STRING,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,STRING,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,STRING,STRING,FLOAT,FLOAT,STRING,INTEGER,STRING,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,STRING,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT,STRING,FLOAT,FLOAT,STRING,INTEGER,STRING,FLOAT,FLOAT,FLOAT,FLOAT,FLOAT
1,RESULT_DESCR,,,,,,,,"Indicates type of activity observed: inhibitor, activator, fluorescent, cytotoxic, inactive, or inconclusive.","Concentration at which compound exhibits half-maximal efficacy, AC50. Extrapolated AC50s also include the highest efficacy observed and the concentration of compound at which it was observed.","Maximal efficacy of compound, reported as a percentage of control. These values are estimated based on fits of the Hill equation to the dose-response curves.",Annotation/notes on a particular compound's data or its analysis.,Activity score.,"A description of dose-response curve quality. A complete curve has two observed asymptotes; a partial curve may not have attained its second asymptote at the highest concentration tested. High efficacy curves exhibit efficacy greater than 80% of control. Partial efficacies are statistically significant, but below 80% of control.",The logarithm of the AC50 from a fit of the data to the Hill equation (calculated based on Molar Units).,The Hill slope from a fit of the data to the Hill equation.,R^2 fit value of the curve. Closer to 1.0 equates to better Hill equation fit.,The asymptotic efficacy from a fit of the data to the Hill equation.,Efficacy at zero concentration of compound from a fit of the data to the Hill equation.,Numerical encoding of curve description for the fitted Hill equation.,"Which dose-response titration points were excluded from analysis based on outlier analysis. Each number represents whether a titration point was (1) or was not (0) excluded, for the titration series going from smallest to highest compound concentrations.",Maximum activity observed for compound (usually at highest concentration tested).,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,"NCGC designation for data stage: 'qHTS', 'qHTS Verification', 'Secondary Profiling'","Indicates type of activity observed: inhibitor, activator, fluorescent, cytotoxic, inactive, or inconclusive.","Concentration at which compound exhibits half-maximal efficacy, AC50. Extrapolated AC50s also include the highest efficacy observed and the concentration of compound at which it was observed.","Maximal efficacy of compound, reported as a percentage of control. These values are estimated based on fits of the Hill equation to the dose-response curves.",Annotation/notes on a particular compound's data or its analysis.,Activity score.,"A description of dose-response curve quality. A complete curve has two observed asymptotes; a partial curve may not have attained its second asymptote at the highest concentration tested. High efficacy curves exhibit efficacy greater than 80% of control. Partial efficacies are statistically significant, but below 80% of control.",The logarithm of the AC50 from a fit of the data to the Hill equation (calculated based on Molar Units).,The Hill slope from a fit of the data to the Hill equation.,R^2 fit value of the curve. Closer to 1.0 equates to better Hill equation fit.,The asymptotic efficacy from a fit of the data to the Hill equation.,Efficacy at zero concentration of compound from a fit of the data to the Hill equation.,Numerical encoding of curve description for the fitted Hill equation.,"Which dose-response titration points were excluded from analysis based on outlier analysis. Each number represents whether a titration point was (1) or was not (0) excluded, for the titration series going from smallest to highest compound concentrations.",Maximum activity observed for compound (usually at highest concentration tested).,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,% Activity at given concentration.,"Indicates type of activity observed: inhibitor, activator, fluorescent, cytotoxic, inactive, or inconclusive.","Concentration at which compound exhibits half-maximal efficacy, AC50. Extrapolated AC50s also include the highest efficacy observed and the concentration of compound at which it was observed.","Maximal efficacy of compound, reported as a percentage of control. These values are estimated based on fits of the Hill equation to the dose-response curves.",Annotation/notes on a particular compound's data or its analysis.,Activity score.,"A description of dose-response curve quality. A complete curve has two observed asymptotes; a partial curve may not have attained its second asymptote at the highest concentration tested. High efficacy curves exhibit efficacy greater than 80% of control. Partial efficacies are statistically significant, but below 80% of control.",The logarithm of the AC50 from a fit of the data to the Hill equation (calculated based on Molar Units).,The Hill slope from a fit of the data to the Hill equation.,R^2 fit value of the curve. Closer to 1.0 equates to better Hill equation fit.,The asymptotic efficacy from a fit of the data to the Hill equation.,Efficacy at zero concentration of compound from a fit of the data to the Hill equation.
2,RESULT_UNIT,,,,,,,,,MICROMOLAR,PERCENT,,,,,,,PERCENT,PERCENT,,,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,,,MICROMOLAR,PERCENT,,,,,,,PERCENT,PERCENT,,,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,PERCENT,,MICROMOLAR,PERCENT,,,,,,,PERCENT,PERCENT
3,RESULT_IS_ACTIVE_CONCENTRATION,,,,,,,,,TRUE,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
4,RESULT_ATTR_CONC_MICROMOL,,,,,,,,,,,,,,,,,,,,,,7.4871e-06,1.71744e-05,6.79832e-05,0.000161656,0.000374473,0.000772804,0.0021195,0.00650591,0.0167264,0.0378057,0.0849477,0.19076,0.434921,1.33026,4.07428,10.458,23.6372,52.9495,115.22,299.646,1087.93,2306,5157,11530,25780,57660,,,,,,,,,,,,,,,,7.4871e-06,1.71744e-05,6.79832e-05,0.000161656,0.000374473,0.000772804,0.0021195,0.00650591,0.0167264,0.0378057,0.0849477,0.19076,0.434921,1.33026,4.07428,10.458,23.6372,52.9495,115.22,299.646,1087.93,2306,5157,11530,25780,57660,,,,,,,,,,,
5,1,144205501.0,17931.0,CN1C(=S)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Inactive,0.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00160641-01/247416155,,Inactive,,,,0,,-4.56,3.0654,0.9067,-17.6107,0,4,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-15.9255,,,,,,0.7206,-0.7335,-0.9289,-2.0335,1.7527,-0.7167,-1.7851,2.4819,-0.9983,-0.4834,1.2576,-8.6278,-15.9255,,,,,,,,,QC'd by Specs,Inhibitor,43.6486,49.316,,10,Single point of activity,-4.36,4.9549,0.8149,-48.5589,0.7571,-3,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-40.4657,,,,,,1.098,0.2956,1.0136,2.9861,3.4353,4.3922,3.0743,2.8971,-16.441,2.2399,0.8497,1.0832,-40.4657,,,,,,,,,Inactive,,,,0,,-4.46,4.9549,0.5429,-22.1925,-0.5
6,2,144206117.0,3045407.0,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)COC6=CC=C(C=C6)OC,Active,41.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00167569-01/247417469,,Inhibitor,17.3768,73.4603,,41,Partial curve; high efficacy,-4.76,2.8473,0.9393,-75.6394,-2.1791,-2.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-78.791,,,,,,-1.4531,0.4904,1.4577,-12.693,0.4237,-0.5512,0.4015,-17.5495,2.6139,-1.0184,-20.0355,-54.3516,-78.791,,,,,,,,,QC'd by Specs,Inhibitor,21.8761,99.6724,,41,Partial curve; high efficacy,-4.66,2.2526,0.9676,-99.6244,0.0481,-2.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-90.2395,,,,,,3.3414,-1.3453,-7.711,2.6342,4.2797,1.5133,-0.1069,0.7683,-1.5275,1.3812,-16.2641,-58.8854,-90.2395,,,,,,,,,Inhibitor,34.6713,54.5609,,20,Partial curve; partial efficacy,-4.46,3.1925,0.9821,-54.428,0.1329
7,3,144206325.0,14708.0,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(CC5=NON=C5C4)C,Inactive,0.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00181290-01/247416639,,Inactive,,,,0,,-4.76,4.9549,0.799,-20.068,-1,4,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-15.8453,,,,,,-7.8792,1.0746,-1.2277,-4.3449,-0.1005,1.145,-0.5211,0.5106,1.521,-0.6314,0.935,-23.39,-15.8453,,,,,,,,,QC'd by ACC,Inhibitor,15.4871,34.3481,,21,Partial curve; partial efficacy,-4.81,1.2475,0.9094,-35.3481,-1,-2.2,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-31.5401,,,,,,-1.9277,-0.2824,-0.3124,-0.3407,0.5778,-9.7791,-0.6642,-1.5643,2.0112,-6.0133,-15.7712,-20.8827,-31.5401,,,,,,,,,Inactive,,,,0,,-4.36,4.9549,0.3523,-24.4644,-1.5
8,4,144206326.0,5432.0,CC1=NC=C(C(=N1)N)CN(C=O)C(=C(CCO)SSC(=C(C)N(CC2=CN=C(N=C2N)C)C=O)CCO)C,Inactive,0.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00181294-01/247416189,,Inactive,,,,0,,,,,0,0,4,,1.575,,,,,,-0.0018,2.4243,1.053,1.0865,2.6711,-0.6652,0.8599,1.4038,1.4005,1.8815,0.293,-0.3859,1.575,,,,,,,,,QC'd by ACC,Inactive,,,,0,,-4.36,4.9549,0.8988,-12.8283,1,4,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-10.6902,,,,,,-0.3679,0.5001,0.709,0.3338,1.2018,2.6216,0.4481,0.281,1.9718,1.687,1.6483,0.8928,-10.6902,,,,,,,,,Inactive,,,,0,,-5.86,4.9549,0.4816,-11.0248,0.5
9,5,144206328.0,54158.0,CC1=CC(=C(C(=C1NC(=O)CN(CC(=O)O)CC(=O)O)C)Br)C,Inactive,0.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00181297-01/247416273,,Inactive,,,,0,,,,,0,0,4,,1.2954,,,,,,0.0586,-0.2324,0.6772,1.4496,1.6247,1.0842,0.3589,2.1446,1.2612,0.9832,0.4361,1.2054,1.2954,,,,,,,,,QC'd by ACC,Inactive,,,,0,,,,,0,0,4,,-4.5686,,,,,,-0.1304,0.752,-2.3546,1.3438,2.5631,0.4557,-0.2423,0.036,1.4598,-0.1653,-0.3837,0.9857,-4.5686,,,,,,,,,Inactive,,,,0,,,,,0,0
10,6,144206329.0,92140.0,CCCC(=O)OC[C@H]([C@H]([C@H](CN1C2=C(C=C(C(=C2)C)C)N=C3C1=NC(=O)NC3=O)OC(=O)CCC)OC(=O)CCC)OC(=O)CCC,Active,82.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00181300-01/247416432,,Inhibitor,8.709,79.4665,,82,Complete curve; high efficacy,-5.06,2.3332,0.9882,-79.5007,-0.0342,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-76.9578,,,,,,0.0615,-0.064,0.6465,2.9604,-0.2225,-0.6792,-8.6354,2.6409,0.3507,-10.1318,-48.4877,-77.3815,-76.9578,,,,,,,,,QC'd by ACC,Inhibitor,8.709,88.9581,,83,Complete curve; high efficacy,-5.06,1.6266,0.9872,-96.3012,-7.3431,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-87.956,,,,,,-5.9256,-10.6209,-9.4623,-9.4678,-5.809,-9.869,-7.8591,0.2434,-7.8423,-24.8904,-61.1216,-88.1879,-87.956,,,,,,,,,Inhibitor,10.964,90.5686,,82,Complete curve; high efficacy,-4.96,2.2526,0.9681,-97.0961,-6.5275
11,7,144206330.0,6505.0,CCCCOC(=O)CC(CC(=O)OCCCC)(C(=O)OCCCC)OC(=O)C,Inactive,0.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00181301-01/247416483,,Inactive,,,,0,,-4.76,2.2526,0.9238,-22.0707,1,4,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-19.6422,,,,,,0.9123,0.947,-0.134,2.946,3.6117,0.4893,1.5817,2.0037,-0.8658,-1.1186,-2.6756,-17.6261,-19.6422,,,,,,,,,QC'd by ACC,Inhibitor,24.5454,30.933,,10,Partial curve; partial efficacy; poor fit,-4.61,2.4064,0.9751,-29.933,1,-2.4,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-26.1941,,,,,,-1.3178,1.1681,0.2773,0.0764,0.1532,1.6377,0.7382,1.0506,-0.3624,2.2833,-2.0944,-15.9646,-26.1941,,,,,,,,,Inhibitor,24.5454,30.8126,,10,Partial curve; partial efficacy; poor fit,-4.61,2.7202,0.9398,-30.3126,0.5
12,8,144206333.0,3045402.0,C1=CC=C(C(=C1)C(=O)[O-])[O-].C1=CC=C(C(=C1)C(=O)[O-])[O-].O.O.O.O.[Mg+2],Inactive,0.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00181305-01/247416835,,Inactive,,,,0,,,,,0,0,4,,-0.4271,,,,,,1.4717,-1.7058,1.2686,1.7299,0.2757,3.6803,1.504,-0.4882,-1.2212,1.3489,0.5054,2.1134,-0.4271,,,,,,,,,QC'd by ACC,Inactive,,,,0,,,,,0,0,4,,-3.652,,,,,,0.9956,-0.0456,-0.6413,1.5532,0.5041,3.5484,-0.3245,2.442,0.5396,2.0433,0.174,1.4229,-3.652,,,,,,,,,Inactive,,,,0,,,,,0,0
13,9,144206369.0,11956149.0,C[C@@H](C(=O)C1=CC=CC=C1)N.Cl,Active,41.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00168262-02/247417172,,Inhibitor,42.1788,77.7148,,41,Partial curve; high efficacy,-4.3749,1.6266,0.9294,-83.2769,-5.5621,-2.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-72.0452,,,,,,,-7.228,-7.7918,-10.9327,-2.3137,0.2211,3.5753,-3.8452,-0.1545,-16.2382,-13.0373,-33.8494,-60.9482,-72.0452,,,,,,,,QC'd by RTI,Inhibitor,47.3254,51.8974,,20,Partial curve; partial efficacy,-4.3249,1.3723,0.971,-53.1352,-1.2378,-2.2,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-46.6098,,,,,,,-0.3049,0.2354,-0.8333,-3.2951,0.36,0.5674,-3.4988,-0.8047,-7.0411,-6.7407,-19.6095,-29.0667,-46.6098,,,,,,,,Inhibitor,94.4265,98.0448,,42,Partial curve; high efficacy,-4.0249,2.3332,0.9553,-101.032,-2.9872
14,10,144206371.0,3058503.0,C[C@@H]1[C@@H](OC(=N1)N)C2=CC=CC=C2,Active,83.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247671-01/247417262,,Inhibitor,9.8139,102.919,,83,Complete curve; high efficacy,-5.0082,1.3437,0.9881,-102.391,0.5284,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-99.7963,,,,,,,-6.3837,0.8339,2.265,5.8927,1.7743,1.6008,3.2001,-7.4809,-22.1457,-55.4167,-74.4096,-92.4997,-99.7963,,,,,,,,QC'd by RTI,Inhibitor,13.8625,112.805,,82,Complete curve; high efficacy,-4.8582,1.21,0.998,-111.215,1.5901,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-102.977,,,,,,,1.126,0.1139,1.6909,0.5384,-0.4565,1.1589,3.0311,-5.5281,-21.554,-45.4644,-69.0004,-90.4877,-102.977,,,,,,,,Inhibitor,9.8139,106.08,,83,Complete curve; high efficacy,-5.0082,1.5386,0.9984,-105.031,1.049
15,11,144206375.0,71580.0,COC1=CC(=CC(=C1OC)OC)CCN.Cl,Inactive,0.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247674-01/247416234,,Inactive,,,,0,,-4.2119,0.5,0.5291,-28.7746,-2,4,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-20.6455,,,,,,,-0.9346,-6.1272,-0.1726,2.6973,0.3362,0.9283,-12.4331,-0.2039,-10.8497,-6.4911,-13.5188,-12.3604,-20.6455,,,,,,,,QC'd by RTI,Inactive,,,,0,,-4.3619,1.7529,0.9691,-25.3352,1.5,4,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-23.196,,,,,,,0.7109,1.1927,1.1196,2.564,0.2524,2.3732,-0.1233,0.0483,1.9553,0.6346,-8.9176,-13.7772,-23.196,,,,,,,,Inactive,,,,0,,-4.1119,2.4064,0.7762,-29.7816,0
16,12,144206376.0,60196310.0,CC(C)CC1=CC(=C(C(=C1)OC)OC)OC.Cl,Inconclusive,20.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247675-01/247416740,,Inhibitor,43.1871,40.4843,,20,Partial curve; partial efficacy,-4.3646,1.9887,0.9662,-40.2736,0.2107,-2.2,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-39.484,,,,,,,-1.4534,-1.3466,0.4309,3.4092,0.8419,0.0392,-0.8048,-0.2477,0.7721,-1.7847,-14.3306,-22.3138,-39.484,,,,,,,,QC'd by RTI,Inhibitor,54.3693,72.2187,,10,Partial curve; high efficacy; poor fit,-4.2646,1.331,0.5649,-90.0033,-17.7845,-2.3,1 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-75.0027,,,,,,,-68.5334,-47.2631,-17.4187,-22.2157,-9.3493,-19.1605,-9.9271,-12.53,-24.0292,-22.1233,-44.1916,-52.5551,-75.0027,,,,,,,,Inhibitor,43.1871,38.7538,,20,Partial curve; partial efficacy,-4.3646,2.0437,0.9825,-37.7593,0.9945
17,13,144206379.0,60196312.0,C[C@H]1[C@@H]2CC3=C([C@]1(CCN2C)C)C=C(C=C3)O.C[C@H]1[C@@H]2CC3=C([C@]1(CCN2C)C)C=C(C=C3)O.C(=C/C(=O)O)\C(=O)O,Active,80.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247677-01/247416117,,Inhibitor,33.9291,88.2191,,80,Complete curve; high efficacy,-4.4694,1,0.9936,-88.1617,0.0574,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-81.6312,,,,,,,,-0.1069,0.5753,-0.9626,2.7951,0.5786,0.7685,-1.7778,-11.8589,-21.4904,-36.842,-51.8369,-70.7618,-81.6312,,,,,,,QC'd by RTI,Inhibitor,38.0691,92.5233,,80,Complete curve; high efficacy,-4.4194,1,0.9953,-92.3843,0.139,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-85.541,,,,,,,,-1.2339,3.0685,1.6054,-1.1266,0.2203,0.5781,-1.3249,-9.9645,-21.6091,-34.7853,-53.1461,-70.8981,-85.541,,,,,,,Inhibitor,38.0691,90.5734,,80,Complete curve; high efficacy,-4.4194,1,0.9847,-88.4112,2.1622
18,14,144206380.0,3041255.0,CC[C@@H](C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2)O.Cl,Active,87.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247678-01/247417258,,Inhibitor,1.4445,94.996,,87,Complete curve; high efficacy,-5.8403,1.1,0.9947,-100.478,-5.4823,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-102.112,,,,,,,-9.9229,-7.5086,-7.0504,-0.3275,-6.9898,-14.1216,-27.4811,-46.2114,-72.0582,-91.3399,-95.1853,-100.425,-102.112,,,,,,,,QC'd by RTI,Inhibitor,1.6207,107.598,,87,Complete curve; high efficacy,-5.7903,1.1,0.9965,-104.87,2.7281,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-105.291,,,,,,,0.7963,-1.2646,3.4346,3.8316,1.0232,-3.2949,-17.2596,-42.3291,-69.2997,-93.7748,-99.1715,-103.204,-105.291,,,,,,,,Inhibitor,0.724,95.1395,,88,Complete curve; high efficacy,-6.1403,0.9,0.9967,-100.433,-5.294
19,15,144206382.0,92942.0,C[C@H](CN1CCOCC1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N4CCCC4.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O,Active,40.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247680-01/247416788,,Inhibitor,43.2933,70.8171,,40,Partial curve; partial efficacy,-4.3636,1.111,0.9802,-71.4045,-0.5874,-2.2,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-59.5037,,,,,,,0.2482,0.4213,0.327,-0.6755,-0.2137,0.2816,0.8957,-0.885,-11.1152,-11.6188,-24.4959,-45.2055,-59.5037,,,,,,,,QC'd by RTI,Inhibitor,43.2933,68.771,,40,Partial curve; partial efficacy,-4.3636,1.4781,0.9599,-67.5521,1.2189,-2.2,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-59.6948,,,,,,,1.7388,-0.5514,1.125,8.1159,-8.9756,1.1987,0.9603,3.0786,3.311,-5.7156,-27.1162,-40.0621,-59.6948,,,,,,,,Inhibitor,48.5759,71.8972,,41,Partial curve; high efficacy,-4.3136,1.5386,0.9843,-71.3411,0.5561
20,16,144206383.0,13493.0,CCN(CC)CCN1C2=C(C=C(C=C2)[N+](=O)[O-])N=C1CC3=CC=C(C=C3)OCC,Active,87.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247681-01/247417344,,Inhibitor,1.6658,105.859,,87,Complete curve; high efficacy,-5.7784,0.8,0.9967,-104.82,1.0395,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-102.164,,,,,,,-0.0299,-5.1221,-1.8772,1.7894,-7.0957,-16.7183,-27.0572,-46.7835,-75.0378,-83.9636,-93.4019,-98.0223,-102.164,,,,,,,,QC'd by RTI,Inhibitor,1.4847,111.592,,87,Complete curve; high efficacy,-5.8284,0.8,0.9946,-108.846,2.746,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-106.088,,,,,,,1.1328,-0.3584,2.413,2.0646,-14.0272,-10.0996,-27.1877,-53.4671,-78.3529,-88.267,-96.8195,-101.686,-106.088,,,,,,,,Inhibitor,1.1793,103.61,,87,Complete curve; high efficacy,-5.9284,0.91,0.999,-100.98,2.6302
21,17,144206384.0,60196314.0,CC[C@@H](C(CC(C)NC)(C1=CC=CC=C1)C2=CC=CC=C2)OC(=O)C.Cl,Active,82.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247682-01/247416603,,Inhibitor,14.2871,92.3776,,82,Complete curve; high efficacy,-4.8451,1.111,0.9905,-94.4549,-2.0773,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-88.4409,,,,,,,0.5094,-3.8873,-6.3627,2.3323,-0.4673,-3.7403,-4.8324,-9.2235,-15.6607,-47.8119,-59.507,-77.1929,-88.4409,,,,,,,,QC'd by RTI,Inhibitor,17.9864,95.2747,,41,Partial curve; high efficacy,-4.7451,1,0.9867,-94.8925,0.3822,-2.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-84.1246,,,,,,,1.2793,0.8568,2.0016,2.0538,-11.1689,-0.0714,0.7265,-1.3135,-15.7603,-37.7021,-55.5157,-70.6222,-84.1246,,,,,,,,Inhibitor,14.2871,97.3097,,82,Complete curve; high efficacy,-4.8451,1.1341,0.9969,-96.9574,0.3523
22,18,144206385.0,3030770.0,CCC(=O)OC1(CCN(CC1)C)C2=CC=CC=C2.Cl,Active,40.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247683-01/247417096,,Inhibitor,37.4511,103.353,,40,Partial curve; high efficacy,-4.4265,0.9,0.9904,-102.971,0.3826,-2.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-78.008,,,,,,,-0.6613,-0.1933,1.2531,3.1661,1.1653,-1.7277,0.8909,-3.0352,-13.4771,-25.846,-41.7286,-64.3579,-78.008,,,,,,,,QC'd by RTI,Inhibitor,18.77,93.9062,,81,Complete curve; high efficacy,-4.7265,1,0.9446,-102.159,-8.2532,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-92.0355,,,,,,,-10.986,-4.5092,-13.9053,-15.6995,-10.5889,-3.8295,-13.6431,-8.8956,-25.0187,-45.5622,-58.6308,-78.2612,-92.0355,,,,,,,,Inhibitor,37.4511,86.824,,40,Partial curve; high efficacy,-4.4265,1,0.9915,-79.824,7
23,19,144206386.0,60977.0,CC(=O)OC1(CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,Active,88.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247684-01/247416238,,Inhibitor,0.7271,105.583,,88,Complete curve; high efficacy,-6.1384,1,0.9931,-102.936,2.6467,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-103.976,,,,,,,1.121,0.7208,1.3424,0.6401,-1.7246,-26.5709,-44.4915,-53.6246,-84.2998,-95.4407,-99.5329,-102.253,-103.976,,,,,,,,QC'd by RTI,Inhibitor,0.4588,107.46,,90,Complete curve; high efficacy,-6.3384,0.8,0.9982,-104.294,3.1662,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-103.466,,,,,,,1.2384,1.4623,-6.662,-11.843,-19.4007,-29.5828,-51.6323,-69.5616,-85.8914,-96.4461,-99.1353,-101.601,-103.466,,,,,,,,Inhibitor,0.5148,102.724,,89,Complete curve; high efficacy,-6.2884,1.1,0.9974,-99.5347,3.1892
24,20,144206389.0,62300.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=C(C=C3)F,Active,90.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247686-01/247417477,,Inhibitor,0.4033,100.062,,90,Complete curve; high efficacy,-6.3944,1,0.9971,-103.835,-3.7728,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-104.883,,,,,,,-1.8562,-6.9975,-9.4269,-8.1776,-21.973,-37.7001,-59.4716,-78.2287,-89.7417,-99.4248,-101.621,-104.115,-104.883,,,,,,,,QC'd by RTI,Inhibitor,0.3594,103.01,,90,Complete curve; high efficacy,-6.4444,1,0.9987,-100.44,2.5701,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-102.073,,,,,,,-0.28,0.6629,0.4093,-7.0479,-17.2291,-34.4493,-58.0501,-74.5676,-89.0098,-96.4843,-98.5088,-100.498,-102.073,,,,,,,,Inhibitor,0.4033,105.226,,90,Complete curve; high efficacy,-6.3944,1,0.999,-102.064,3.1625
25,21,144206390.0,60196316.0,CCC(=O)N([C@@H]1CCN(C[C@@H]1C)CCC2=CC=CC=C2)C3=CC=CC=C3.Cl,Active,87.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247687-01/247416950,,Inhibitor,1.2715,104.397,,87,Complete curve; high efficacy,-5.8957,0.9,0.997,-102.335,2.0628,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-101.522,,,,,,,0.4439,0.3817,1.6186,0.9289,-11.1353,-11.4406,-31.7026,-42.6634,-71.2912,-89.871,-94.8831,-98.5984,-101.522,,,,,,,,QC'd by RTI,Inhibitor,1.01,102.136,,88,Complete curve; high efficacy,-5.9957,1,0.9969,-102.664,-0.528,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-104.334,,,,,,,1.0106,0.6207,-4.3039,-7.9278,-13.308,-15.6512,-29.4005,-50.0982,-80.088,-92.8074,-97.1757,-101.338,-104.334,,,,,,,,Inhibitor,1.01,108.002,,88,Complete curve; high efficacy,-5.9957,1,0.9956,-104.698,3.3038
26,22,144206392.0,60196318.0,CCC(=O)N(C1CCN(CC1)CC2=CC=CC=C2)C3=CC=CC=C3.Cl,Active,86.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247689-01/247416564,,Inhibitor,1.8304,106.082,,86,Complete curve; high efficacy,-5.7374,1,0.9962,-103.409,2.6736,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-104.453,,,,,,,2.3364,0.7264,-0.8742,2.4913,2.237,-8.3666,-17.5158,-40.5692,-65.6604,-86.5326,-94.7407,-100.535,-104.453,,,,,,,,QC'd by RTI,Inhibitor,1.2959,104.299,,87,Complete curve; high efficacy,-5.8874,0.8,0.9955,-104.816,-0.5168,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-102.761,,,,,,,0.6029,-0.5141,-7.2643,-7.4153,-16.9522,-13.4983,-33.981,-44.8355,-72.2499,-90.9851,-95.6572,-100.178,-102.761,,,,,,,,Inhibitor,2.0538,113.318,,87,Complete curve; high efficacy,-5.6874,1.1,0.9933,-110.956,2.3626
27,23,144206393.0,60196319.0,CCC1=CC(=C(C=C1OC)C[C@H](C)N)OC.Cl,Active,84.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247690-01/247417339,,Inhibitor,4.1633,101.568,,84,Complete curve; high efficacy,-5.3806,0.8,0.9979,-99.1697,2.3987,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-93.9107,,,,,,,1.7009,0.0368,2.1021,0.3153,1.0555,-8.0917,-11.9629,-24.7756,-44.7207,-67.0262,-80.9389,-88.1612,-93.9107,,,,,,,,QC'd by RTI,Inhibitor,5.2413,102.597,,84,Complete curve; high efficacy,-5.2806,0.8,0.9965,-102.645,-0.0474,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-94.5165,,,,,,,0.7073,0.3501,-5.7757,0.4845,-7.7681,-4.0411,-11.791,-22.6646,-42.7141,-67.4004,-79.0637,-89.1173,-94.5165,,,,,,,,Inhibitor,5.2413,103.128,,84,Complete curve; high efficacy,-5.2806,0.8,0.9963,-100.645,2.4829
28,24,144206395.0,118031.0,CC(CC1=CC2=C(C(=C1)OC)OCO2)N.Cl,Active,86.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247692-01/247417337,,Inhibitor,2.0896,111.421,,86,Complete curve; high efficacy,-5.6799,1,0.9972,-108.63,2.7904,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-107.13,,,,,,,1.8405,0.9719,4.4862,-0.0472,3.1504,-11.7413,-13.9123,-33.5764,-67.2565,-91.5681,-100.683,-105.067,-107.13,,,,,,,,QC'd by RTI,Inhibitor,2.6306,112.393,,86,Complete curve; high efficacy,-5.5799,1.2221,0.9937,-109.481,2.9116,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-109.921,,,,,,,-0.0164,-1.3758,6.5421,-2.1346,4.6237,5.4201,-5.7977,-26.9767,-63.9556,-91.8411,-102.568,-107.617,-109.921,,,,,,,,Inhibitor,2.6306,107.729,,86,Complete curve; high efficacy,-5.5799,1.2221,0.9928,-105.54,2.1898
29,25,144206396.0,60196321.0,CCC(=O)N(C1CCN(CC1)CC(C2=CC=CC=C2)O)C3=CC=CC=C3.Cl,Active,87.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247693-01/247417261,,Inhibitor,1.4151,102.752,,87,Complete curve; high efficacy,-5.8492,0.9,0.9985,-101.741,1.011,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-99.746,,,,,,,-0.5574,-0.2023,0.0177,-1.9658,-4.6934,-16.1114,-25.0041,-40.3896,-70.6415,-86.8337,-94.584,-97.5794,-99.746,,,,,,,,QC'd by RTI,Inhibitor,1.4151,105.437,,87,Complete curve; high efficacy,-5.8492,0.8,0.9982,-101.37,4.0676,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-98.8007,,,,,,,2.2751,1.5668,-0.2521,-0.4125,-7.4475,-9.6086,-27.8658,-40.433,-66.9362,-84.7872,-91.6182,-95.7726,-98.8007,,,,,,,,Inhibitor,1.124,102.135,,87,Complete curve; high efficacy,-5.9492,1,0.9952,-99.488,2.6474
30,26,144206397.0,60196322.0,CCC(=O)N(C1CCN(CC1)C(C)CC2=CC=CS2)C3=CC=CC=C3.Cl,Active,91.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247694-01/247416585,,Inhibitor,0.2279,97.573,,91,Complete curve; high efficacy,-6.6422,1.3443,0.9983,-99.8931,-2.3202,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-102.771,,,,,,,-2.3519,-3.4553,-5.9608,-9.0022,-22.5842,-49.0011,-74.983,-86.5058,-94.974,-99.0615,-100.462,-101.809,-102.771,,,,,,,,QC'd by RTI,Inhibitor,0.287,101.095,,90,Complete curve; high efficacy,-6.5422,1.2475,0.9984,-100.572,0.5236,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-102.834,,,,,,,1.8913,-1.9651,-0.9874,-8.2146,-18.6953,-37.5091,-65.0094,-83.7095,-94.0261,-98.1221,-99.984,-101.582,-102.834,,,,,,,,Inhibitor,0.2557,106.223,,91,Complete curve; high efficacy,-6.5922,1.2475,0.999,-105.125,1.0973
31,27,144206398.0,60196323.0,CCC(=O)N(C1CCN(CC1C)CCC2=CC=CS2)C3=CC=CC=C3.Cl,Active,90.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247695-01/247416142,,Inhibitor,0.3067,101.048,,90,Complete curve; high efficacy,-6.5133,1.111,0.9989,-100.537,0.5114,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-102.172,,,,,,,-1.0349,0.1156,-4.1055,-6.7733,-19.4085,-37.9007,-63.2945,-84.5804,-94.0939,-96.8469,-99.953,-100.978,-102.172,,,,,,,,QC'd by RTI,Inhibitor,0.3067,104.401,,90,Complete curve; high efficacy,-6.5133,1,0.9983,-103.343,1.0585,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-105.668,,,,,,,0.1156,-0.1118,-6.6884,-8.2509,-24.6412,-36.4378,-61.1244,-84.9847,-95.8582,-99.2458,-101.921,-104.014,-105.668,,,,,,,,Inhibitor,0.3067,102.911,,90,Complete curve; high efficacy,-6.5133,1.111,0.9993,-102.911,0
32,28,144206399.0,46783063.0,CCC(=O)N(C1CCN(CC1)CC2=CC=CS2)C3=CC=CC=C3.Cl,Active,87.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247696-01/247417254,,Inhibitor,1.2724,107.749,,87,Complete curve; high efficacy,-5.8954,1.111,0.9966,-106.094,1.656,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-107.165,,,,,,,-1.9743,-0.3287,-2.0407,1.9829,3.2337,-12.6017,-24.2243,-45.4276,-77.6616,-95.5481,-101.766,-105.357,-107.165,,,,,,,,QC'd by RTI,Inhibitor,1.4277,109.91,,87,Complete curve; high efficacy,-5.8454,1.031,0.9917,-107.659,2.2502,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-108.092,,,,,,,2.7612,0.2741,4.4207,4.2333,-14.4126,-3.1206,-26.0392,-44.0136,-76.6663,-92.3367,-100.889,-104.433,-108.092,,,,,,,,Inhibitor,0.6377,108.199,,89,Complete curve; high efficacy,-6.1954,1,0.9927,-106.53,1.6692
33,29,144206400.0,60196324.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CS2)C3=CC=CC=C3.Cl,Active,88.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247697-01/247416450,,Inhibitor,0.8981,110.059,,88,Complete curve; high efficacy,-6.0467,1.1341,0.9979,-106.202,3.8575,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-106.628,,,,,,,3.3653,0.7407,3.3361,3.2945,-0.5736,-15.1781,-32.1961,-52.2967,-85.9523,-99.548,-102.675,-105.062,-106.628,,,,,,,,QC'd by RTI,Inhibitor,0.7134,95.298,,88,Complete curve; high efficacy,-6.1467,1.21,0.9968,-98.8747,-3.5766,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-101.723,,,,,,,-1.7312,-6.1652,-3.9414,-5.5384,-12.3286,-15.9923,-41.5243,-63.2043,-85.0943,-93.4429,-96.6527,-99.1463,-101.723,,,,,,,,Inhibitor,0.7134,100.437,,88,Complete curve; high efficacy,-6.1467,1.6259,0.997,-97.7932,2.6437
34,30,144206401.0,60196325.0,CC1=CC(=C(C=C1OC)C[C@@H](C)N)OC.Cl,Active,41.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247698-01/247416848,,Inhibitor,47.9191,95.0626,,41,Partial curve; high efficacy,-4.3195,0.9,0.9227,-103.725,-8.6621,-2.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-78.5793,,,,,,,-21.2572,-9.6441,-1.6916,-0.7311,-2.321,-14.5356,-16.6049,-13.6343,-14.858,-36.418,-39.8858,-61.0872,-78.5793,,,,,,,,QC'd by RTI,Inhibitor,33.9241,85.2993,,40,Partial curve; high efficacy,-4.4695,1.21,0.8564,-93.5542,-8.2549,-2.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-81.1016,,,,,,,-25.1982,-12.5854,-3.4839,-4.3622,-29.0411,1.4471,0.7618,-1.2395,-16.9268,-27.6307,-43.5374,-64.1352,-81.1016,,,,,,,,Inhibitor,42.708,102.422,,41,Partial curve; high efficacy,-4.3695,0.9,0.9695,-106.369,-3.9473
35,31,144206403.0,62786.0,CC(CC1=C(C=CC(=C1)OC)OC)N.Cl,Active,83.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00168269-02/247417008,,Inhibitor,7.6213,103.229,,83,Complete curve; high efficacy,-5.118,0.9,0.9945,-102.531,0.698,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-94.9365,,,,,,,0.1479,-0.1888,-1.0306,3.0839,0.3027,-2.6592,-6.0387,-20.0871,-31.0719,-64.8013,-77.4944,-88.5075,-94.9365,,,,,,,,QC'd by RTI,Inhibitor,6.7925,105.432,,83,Complete curve; high efficacy,-5.168,0.9,0.9976,-103.928,1.5038,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-97.8611,,,,,,,-1.099,1.4476,0.3701,-0.016,-0.4249,1.604,-8.4474,-17.914,-35.1993,-65.7898,-79.2982,-91.49,-97.8611,,,,,,,,Inhibitor,4.2858,97.777,,84,Complete curve; high efficacy,-5.368,1.031,0.9968,-95.0314,2.7457
36,32,144206405.0,60196328.0,CC(CC1=CC2=C(C=C1)OCO2)NO.Cl,Active,41.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247701-01/247416159,,Inhibitor,38.5707,121.213,,41,Partial curve; high efficacy,-4.4137,1.3723,0.9724,-125.398,-4.1847,-2.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-103.463,,,,,,,-1.6219,0.3467,-0.4977,0.5811,-1.4253,-8.1976,-11.5349,-10.2549,-15.1848,-24.4847,-41.7869,-91.8544,-103.463,,,,,,,,QC'd by RTI,Inhibitor,48.5576,110.337,,41,Partial curve; high efficacy,-4.3137,1.5579,0.9438,-112.605,-2.2686,-2.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-110.397,,,,,,,-0.9474,2.7958,2.3623,1.452,-3.743,-0.5949,-11.4524,-1.0675,-8.2928,-19.3,-35.844,-52.8156,-110.397,,,,,,,,Inhibitor,34.3762,126.94,,80,Complete curve; high efficacy,-4.4637,1.4163,0.9772,-128.028,-1.0879
37,33,144206411.0,60196330.0,CCN[C@@H](C)CC1=CC=CC=C1.Cl,Active,84.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247705-01/247416441,,Inhibitor,6.2786,102.643,,84,Complete curve; high efficacy,-5.2021,1,0.9965,-101.122,1.5216,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-97.9862,,,,,,,-1.5727,0.7925,1.2069,1.7977,1.2045,0.4886,-5.8358,-18.2402,-35.4939,-69.233,-78.2038,-92.9373,-97.9862,,,,,,,,QC'd by RTI,Inhibitor,7.0447,108.792,,84,Complete curve; high efficacy,-5.1521,0.9,0.9987,-107.784,1.0089,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-99.7995,,,,,,,-0.5213,0.241,0.4535,-1.9808,1.0878,-1.2795,-7.6903,-17.8103,-37.7667,-68.2963,-82.1857,-94.6998,-99.7995,,,,,,,,Inhibitor,4.9873,110.163,,84,Complete curve; high efficacy,-5.3021,1,0.9963,-106.9,3.2628
38,34,144206412.0,31331.0,CC(CC(C#N)(C1=CC=CC=C1)C2=CC=CC=C2)N(C)C,Active,82.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247341-02/247416705,,Inhibitor,11.1945,103.25,,82,Complete curve; high efficacy,-4.951,0.9,0.9954,-102.492,0.7579,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-94.8998,,,,,,,0.2385,-0.0158,-0.901,2.5214,0.7016,-5.4149,-1.4142,-14.5372,-30.0132,-51.3888,-65.2732,-79.1983,-94.8998,,,,,,,,QC'd by RTI,Inhibitor,28.1193,115.945,,40,Partial curve; high efficacy,-4.551,1,0.9921,-114.706,1.2384,-2.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-92.8043,,,,,,,0.6418,-0.3069,-0.866,-1.7766,4.8117,0.3413,3.739,-1.166,-17.8384,-33.5852,-49.716,-71.604,-92.8043,,,,,,,,Inhibitor,25.0614,112.973,,41,Partial curve; high efficacy,-4.601,1.111,0.9948,-110.606,2.3668
39,35,144206414.0,6321225.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O.CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O.O.O.O.O.O.OS(=O)(=O)O,Inconclusive,20.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247707-01/247416832,,Inhibitor,39.362,45.1201,,20,Partial curve; partial efficacy,-4.4049,1.21,0.9154,-48.1201,-3,-2.2,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-38.9842,,,,,,,-0.3505,-5.5819,0.7818,-5.6484,-0.7541,-11.3596,-1.5263,-3.8902,-6.4141,-11.0018,-17.4438,-28.7156,-38.9842,,,,,,,,QC'd by RTI,Inhibitor,39.362,43.3294,,20,Partial curve; partial efficacy,-4.4049,1.5095,0.9702,-42.4131,0.9163,-2.2,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-39.2714,,,,,,,1.1741,0.7332,0.5173,1.5705,0.6938,1.5762,-0.7352,0.7804,0.0445,-7.4115,-13.2345,-20.771,-39.2714,,,,,,,,Inhibitor,39.362,44.1837,,20,Partial curve; partial efficacy,-4.4049,1.8617,0.9673,-42.9921,1.1915
40,36,144206415.0,21124389.0,C1CN[C@@H]2CC3=C4[C@@]15[C@H]2C=C[C@@H]([C@@H]5OC4=C(C=C3)O)O.Cl,Inconclusive,20.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247708-01/247416304,,Inhibitor,36.6547,36.8264,,20,Partial curve; partial efficacy,-4.4359,2.4064,0.8694,-38.8264,-2,-2.2,0 0 0 0 0 0 0 0 0 0 0 0 0 0 1,-23.5612,,,,,,,-0.2073,0.7152,0.869,-0.8975,-3.7937,-9.2208,-0.0212,-4.8335,-2.6535,-6.595,-10.179,-30.6887,-23.5612,,,,,,,,QC'd by RTI,Inhibitor,41.1273,31.5236,,10,Partial curve; partial efficacy; poor fit,-4.3859,1.5386,0.9446,-30.0236,1.5,-2.4,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-26.6863,,,,,,,2.2841,2.9441,0.5854,-1.1963,1.7529,-0.6802,0.9545,-1.0507,1.7395,-0.1553,-12.6461,-15.353,-26.6863,,,,,,,,Inhibitor,36.6547,36.6827,,10,Partial curve; partial efficacy; poor fit,-4.4359,0.7,0.8977,-23.6827,13
41,37,144206418.0,16219349.0,CCN[C@H](C)CC1=CC(=CC=C1)C(F)(F)F.Cl,Active,86.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00159473-05/247416830,,Inhibitor,2.2354,103.684,,86,Complete curve; high efficacy,-5.6506,0.8,0.9975,-103.593,0.0914,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-98.6598,,,,,,,-0.6785,0.2046,0.4266,-4.9884,-9.4375,-14.5544,-19.3061,-40.2632,-64.7254,-83.9614,-88.8505,-96.3652,-98.6598,,,,,,,,QC'd by RTI,Inhibitor,1.9923,103.387,,86,Complete curve; high efficacy,-5.7006,1,0.9964,-101.831,1.5562,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-102.24,,,,,,,0.2522,1.5063,-0.8815,-1.6958,0.7395,-1.8717,-16.5519,-43.7159,-67.8838,-83.9467,-91.9975,-99.6501,-102.24,,,,,,,,Inhibitor,2.2354,111.249,,86,Complete curve; high efficacy,-5.6506,1,0.9931,-106.81,4.4388
42,38,144206419.0,2164.0,CCC1(C(=O)NC(=O)NC1=O)CCC(C)C,Inactive,0.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247711-01/247417033,,Inactive,,,,0,,,,,0,0,4,,1.6631,,,,,,,0.7661,0.5727,1.0186,1.8598,-0.407,-6.7573,-0.5041,-0.4265,0.2678,-0.5998,-0.5207,0.4797,1.6631,,,,,,,,QC'd by RTI,Inactive,,,,0,,,,,0,0,4,,4.0368,,,,,,,-0.3708,2.0562,3.8065,3.1937,0.4483,-0.7652,4.2874,3.3236,-1.7719,2.8213,3.6453,0.215,4.0368,,,,,,,,Inactive,,,,0,,-4.0071,4.9549,0.8854,-25.8911,1
43,39,144206420.0,31143.0,CCC[C@@H](C)C1(C(=O)NC(=O)NC1=O)CC=C,Inactive,0.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247331-02/247416783,,Inactive,,,,0,,,,,0,0,4,,1.0344,,,,,,,-2.2801,-0.9522,-0.5457,1.3052,0.5533,0.4688,1.2828,-0.2951,-4.8834,-6.9258,-0.0153,0.4053,1.0344,,,,,,,,QC'd by RTI,Inactive,,,,0,,,,,0,0,4,,3.7975,,,,,,,2.3849,-12.4301,-1.3305,0.2058,1.0315,0.4398,2.5068,-1.8273,-1.1033,-10.5097,3.39,3.0655,3.7975,,,,,,,,Inactive,,,,0,,,,,0,0
44,40,144206423.0,9567.0,CC1=NC2=CC=CC=C2C(=O)N1C3=CC=CC=C3Cl,Inconclusive,21.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247713-01/247416561,,Inhibitor,78.0193,52.9965,,21,Partial curve; partial efficacy,-4.1078,2.8473,0.8741,-55.8694,-2.873,-2.2,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-42.3253,,,,,,,-8.2257,-5.0214,0.7516,-0.0082,-7.0351,0.9081,1.3976,0.0244,1.4045,-9.7246,-4.6288,-14.0798,-42.3253,,,,,,,,QC'd by RTI,Inactive,,,,0,,-8.6578,2.1876,0.6408,-1.5,-33.9523,4,0 0 0 0 0 0 0 0 0 0 0 0 0 0 1,-24.575,,,,,,,-17.4228,-6.0742,0.4658,2.3287,-16.0045,1.2146,-0.1029,0.8299,1.778,1.9823,-2.0151,-6.2511,-24.575,,,,,,,,Inactive,,,,0,,-4.1078,4.045,0.6663,-26.3161,0
45,41,144206425.0,5761.0,CCN(CC)C(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C,Active,90.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00168265-02/247416692,,Inhibitor,0.4659,114.09,,90,Complete curve; high efficacy,-6.3317,0.8,0.998,-108.622,5.4678,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-107.76,,,,,,,,0.7331,0.9473,-8.3457,-20.8258,-33.0057,-49.3898,-64.9468,-91.6009,-100.394,-103.469,-105.192,-106.738,-107.76,,,,,,,QC'd by RTI,Inhibitor,0.4152,109.745,,90,Complete curve; high efficacy,-6.3817,0.9,0.9995,-105.956,3.7894,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-106.381,,,,,,,,1.146,-0.2541,-9.3137,-18.687,-34.0863,-50.9541,-71.2289,-90.9882,-100.397,-102.467,-104.36,-105.275,-106.381,,,,,,,Inhibitor,0.4152,119.124,,91,Complete curve; high efficacy,-6.3817,0.9,0.9952,-111.971,7.1528
46,42,144206427.0,60196332.0,C[C@H](CC1=CC(=C(C=C1OC)Br)OC)N.Cl,Active,82.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00168267-02/247416758,,Inhibitor,11.5577,112.105,,82,Complete curve; high efficacy,-4.9371,0.8,0.997,-108.989,3.1151,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-95.6047,,,,,,,1.5262,2.8612,1.96,-1.5742,3.2442,-0.2453,-0.7485,-14.0671,-28.2045,-51.8752,-69.3441,-84.9338,-95.6047,,,,,,,,QC'd by RTI,Inhibitor,10.3008,103.836,,83,Complete curve; high efficacy,-4.9871,0.9,0.9974,-103.353,0.4837,-1.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-94.1279,,,,,,,-0.7245,-0.4212,-0.9559,-1.1698,1.035,-0.1569,-1.3912,-11.5005,-30.5098,-52.8743,-71.8726,-84.6975,-94.1279,,,,,,,,Inhibitor,10.3008,108.823,,83,Complete curve; high efficacy,-4.9871,0.8,0.9944,-105.309,3.5136
47,43,144206428.0,151318.0,COC1=CC(=C(C=C1CCN)OC)Br.Cl,Active,40.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00168259-02/247416590,,Inhibitor,26.0434,112.338,,40,Partial curve; high efficacy,-4.5843,0.8,0.9867,-112.355,-0.0168,-2.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-87.9144,,,,,,,1.8016,1.6323,-1.1136,0.8365,-1.1999,2.0095,-12.5258,-13.6539,-15.6252,-41.0405,-55.2744,-74.4987,-87.9144,,,,,,,,QC'd by RTI,Inhibitor,29.2211,116.148,,40,Partial curve; high efficacy,-4.5343,0.9,0.9985,-115.596,0.5514,-2.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-93.0728,,,,,,,1.4136,0.2029,-0.5067,-1.3429,-0.3247,0.4024,-0.8629,-6.246,-15.6187,-36.128,-52.5628,-74.0575,-93.0728,,,,,,,,Inhibitor,23.2112,106.124,,41,Partial curve; high efficacy,-4.6343,1,0.9766,-106.163,-0.0391
48,44,144206430.0,12259683.0,C[C@H]1[C@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O.C(CC(=O)O)C(=O)O,Inconclusive,10.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00247351-03/247416746,,Inhibitor,0.3124,54.5684,,10,Complete curve; high efficacy; poor fit,-6.5053,0.7,0.999,-105.94,-51.372,-1.3,1 1 1 1 0 0 0 0 0 0 0 0 0 0 0,-105.1,,,,,,,-91.0615,-83.805,-77.0925,-63.538,-64.2617,-72.5928,-82.266,-91.6925,-98.4542,-101.774,-103.304,-104.51,-105.1,,,,,,,,QC'd by RTI,Inhibitor,0.3933,66.4726,,90,Complete curve; high efficacy,-6.4053,1.6259,0.9667,-104.77,-38.2974,-1.1,1 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-107.127,,,,,,,-65.7728,-40.315,-31.6987,-29.6225,-38.5368,-58.4901,-71.8924,-94.3736,-101.742,-104.481,-105.476,-106.465,-107.127,,,,,,,,Inhibitor,0.4951,65.4239,,90,Complete curve; high efficacy,-6.3053,1.4641,0.947,-105.411,-39.9868
49,9662,251919986.0,47364.0,C[As+](C)(C)CC(=O)[O-],Inactive,0.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00357240-01/247409808,,Inactive,,,,0,,-3.9989,4.9549,0.45,-12.5624,0,4,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-9.6353,,,,,,,-2.4943,4.0745,0.0199,3.5037,0.803,-3.1353,2.1711,-1.7748,-2.3828,0.5023,1.1303,2.3401,-9.6353,,,,,,,,QC'd by Sigma Chemical Company,Inactive,,,,0,,,,,0,0,4,,-3.8271,,,,,,,-3.3816,-17.8581,-14.4063,-6.9953,-10.0072,-32.1771,-7.117,-6.3996,0.8075,-6.6563,-26.1726,-24.5635,-3.8271,,,,,,,,Inactive,,,,0,,-4.4489,4.9549,0.9316,-26.24,-1.5
50,9663,251919987.0,23664984.0,CCC1=C(C(=CC=C1)CC)N(COC)C(=O)CS(=O)(=O)[O-].[Na+],Inactive,0.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00357004-01/247409910,,Inactive,,,,0,,,,,0,0,4,,-6.4388,,,,,,,-3.1962,-1.4229,-0.1324,4.364,-9.2593,0.1451,-1.6563,7.6777,-7.308,4.8227,0.0658,-2.9858,-6.4388,,,,,,,,QC'd by EPA,Inhibitor,89.3584,96.7062,,42,Partial curve; high efficacy,-4.0489,3.99,0.8268,-102.784,-6.0784,-2.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-77.8671,,,,,,,-10.7,-12.81,-16.4311,2.6541,-0.667,2.7088,-19.5659,3.6305,4.4195,-16.7303,-5.888,-15.5467,-77.8671,,,,,,,,Inactive,,,,0,,-4.6989,2.7202,0.4894,9,-2.0072
51,9664,251919988.0,2724429.0,CCCC(C(CO)O)O,Inactive,0.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00357186-01/247410133,,Inactive,,,,0,,,,,0,0,4,,0.9177,,,,,,,-0.4797,0.3841,-3.465,4.9834,-1.2626,3.0385,4.6047,5.5267,5.4841,-3.1877,3.8065,-2.6668,0.9177,,,,,,,,QC'd by Sigma Chemical Company,Inhibitor,89.3584,67.0154,,10,Single point of activity,-4.0489,4.9549,0.8217,-66.0185,0.9969,-3,0 0 1 0 0 0 0 0 0 0 0 0 0 0 0,-52.3956,,,,,,,-0.9519,-41.2932,-2.3031,4.5593,4.6756,0.2499,1.7938,4.6016,4.8696,7.6354,-19.5122,-1.2309,-52.3956,,,,,,,,Inactive,,,,0,,,,,0,0
52,9665,251919989.0,13059052.0,CC(C)(C1=CC(=C(C=C1)O)C2=CC=CC=C2)C3=CC(=C(C=C3)O)C4=CC=CC=C4,Active,42.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00357017-01/247409318,,Inhibitor,63.2609,109.569,,42,Partial curve; high efficacy,-4.1989,3.132,0.9253,-109.043,0.5266,-2.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-95.1505,,,,,,,-3.388,3.4985,3.4619,4.0627,2.4243,-0.5601,-0.5533,-5.6493,7.6502,1.8656,-0.5042,-35.523,-95.1505,,,,,,,,QC'd by MRIGlobal,Inhibitor,70.9799,130.751,,42,Partial curve; high efficacy,-4.1489,2.5884,0.9332,-128.402,2.3495,-2.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-99.5362,,,,,,,2.1786,2.3745,-1.7206,-9.649,17.94,0.7996,-10.5844,7.2175,11.0777,4.6177,-8.5452,-35.1426,-99.5362,,,,,,,,Inhibitor,70.9799,122.233,,42,Partial curve; high efficacy,-4.1489,3.9295,0.9824,-117.078,5.1554
53,9666,251919990.0,14178379.0,C1=CC=C(C=C1)COC2=CC=C(C=C2)S(=O)(=O)C3=CC=CC=C3O,Inconclusive,10.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00357019-01/247409618,,Inhibitor,79.6407,85.5095,,10,Partial curve; high efficacy; poor fit,-4.0989,1.4641,0.5898,-89.8573,-4.3478,-2.3,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-68.0737,,,,,,,-23.1445,-5.9325,4.2134,5.4042,2.1304,1.7446,1.1053,2.4456,-5.0086,-34.6206,-9.2624,-18.7136,-68.0737,,,,,,,,QC'd by MRIGlobal,Inhibitor,31.7055,94.0821,,40,Partial curve; high efficacy,-4.4989,1.7529,0.978,-90.2618,3.8203,-2.1,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-83.5757,,,,,,,7.6383,3.6937,-0.8036,5.4509,7.2381,1.9539,-5.1668,7.5844,-1.8232,-10.6214,-27.3013,-59.8395,-83.5757,,,,,,,,Inhibitor,79.6407,100.696,,42,Partial curve; high efficacy,-4.0989,2.9523,0.9749,-97.6746,3.021
54,9667,251919991.0,,,Inactive,0.0,http://assay.nih.gov/htsws/rest/display/tox21-p450-2d6-p1/NCGC00357192-01/247410402,,Inactive,,,,0,,,,,0,0,4,,-4.5393,,,,,,,0.393,-5.9039,3.2235,-7.5073,2.4474,0.968,-0.4816,4.9458,5.5411,8.5997,-1.0576,-1.825,-4.5393,,,,,,,,QC'd by Sigma Chemical Company,Inhibitor,89.3584,105.764,,10,Single point of activity,-4.0489,4.9549,0.9352,-103.883,1.8814,-3,0 0 0 0 0 0 0 0 0 0 0 0 0 0 0,-80.9719,,,,,,,-6.1622,2.5556,1.2326,5.1446,11.4001,3.4414,-0.0654,-2.2729,9.6691,1.0835,1.9853,3.1947,-80.9719,,,,,,,,Inactive,,,,0,,,,,0,0
